Abu Dhabi, United Arab Emirates; March 29, 2020: Group 42 (G42), the leading technology company based in Abu Dhabi, and global genomics leader BGI announced today the launch of a new massive-throughput laboratory built to address the need for population-scale detection and diagnosis of COVID-19 in the United Arab Emirates. The lab is capable of conducting tens of thousands RT-PCR tests per day and is the first in the world of this scale to be operational outside of China. The lab showcases the ...

SAN JOSE, CA, March 30, 2020-- Global genomics leader BGI Group is providing SARS-CoV-2 test kits, automated sample preparation equipment and viral RNA extraction reagent to enable the diagnosis of new coronavirus cases in the Kansas City region through an innovative partnership with local business leaders and The University of Kansas Health System. Responding to a request by a group of business leaders to quickly build additional testing ability for their community, BGI immediately mobili...

STOCKHOLM, Sweden and SHENZHEN, China, March 25, 2020- The Swedish Karolinska Institutet (KI) and MGI announced they will jointly build a multi-omics testing laboratory for the detection of novel coronavirus in the Swedish capital Stockholm. The laboratory has two purposes of virus detection and scientific research. It integrates three methods of detection, namely qPCR, high-throughput sequencing, and antibodies. It is equipped with high-throughput sequencer and automated sample preparation ...

In response to the recent outbreak of the new coronavirus COVID-19, BGI Research and MGI are initiating scientific collaborations in Europe, which will support scientific research and technology development based on the DNBSEQ platform, such as development of novel coronavirus detection methods, virus mutation monitoring, tracing, pathogenesis, prediction, and treatment of infection. In face of the war against novel coronavirus, MGI’s DNBSEQ series of high-throughput sequencers are used ...

On March 15th, the RNA Research Center of IBS (Institute of Basic Science) of the Seoul National University and Korea Centers for Disease Control & Prevention used MGI’s DNBSEQ™ technology with Nanopore single-molecule sequencing technology to analyze the total RNA of Vero cells infected by the novel coronavirus. The analysis, combined with previous research, provided high-definition maps of the novel coronavirus transcriptome and epitranscriptome. Sequencing data shows that the sequenc...

With the in-depth development of "precision medicine", high-throughput sequencing technology has ushered in greater development space, and the industry has also put forward higher requirements for its accuracy, comprehensiveness, and sensitivity. In the face of such requirements, at the 2019 International Genomics Conference (ICG-14), MGI made a series of antibody-based sequencing reagents; the CoolMPS high-throughput sequencing reagent kit was released. According to public information, C...